APA

Brandwein J. M., Leber B. F., Howson-Jan K., Schimmer A. D., Schuh A. C., Gupta V., Yee K. W. L., Wright J., Moore M., MacAlpine K. & Minden M. D. (20090504). A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over. : Leukemia.

Chicago

Brandwein J M, Leber B F, Howson-Jan K, Schimmer A D, Schuh A C, Gupta V, Yee K W L, Wright J, Moore M, MacAlpine K and Minden M D. 20090504. A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over. : Leukemia.

Harvard

Brandwein J. M., Leber B. F., Howson-Jan K., Schimmer A. D., Schuh A. C., Gupta V., Yee K. W. L., Wright J., Moore M., MacAlpine K. and Minden M. D. (20090504). A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over. : Leukemia.

MLA

Brandwein J M, Leber B F, Howson-Jan K, Schimmer A D, Schuh A C, Gupta V, Yee K W L, Wright J, Moore M, MacAlpine K and Minden M D. A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over. : Leukemia. 20090504.